Preventive effects of dietary hydroxytyrosol acetate, an extra virgin olive oil polyphenol in murine collagen-induced arthritis

Molecular Nutrition and Food Research

Volumn 59, Issue 12, 2015, Pages 2537-2546

  Rosillo, María Angeles ^a   Sánchez Hidalgo, Marina ^a   González Benjumea, Alejandro ^a   Fernández Bolaños, José G ^a   Lubberts, Erik ^b   Alarcón de la Lastra, Catalina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CIA; EVOO; Hydroxytyrosol acetate; Inflammation; Rheumatoid arthritis

Indexed keywords

ACETIC ACID DERIVATIVE; AUTOANTIBODY; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CATECHOL DERIVATIVE; COLLAGEN; CYCLOOXYGENASE 2; CYTOKINE; HYDROXYTYROSYL ACETATE; MMP3 PROTEIN, MOUSE; OLIVE OIL; PROSTAGLANDIN E SYNTHASE; PTGES PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; STROMELYSIN;

ANIMAL; ARTHRITIS, EXPERIMENTAL; BLOOD; CHEMICALLY INDUCED; DBA MOUSE; DIETARY SUPPLEMENT; METABOLISM;

ACETATES; ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CATECHOLS; COLLAGEN; CYCLOOXYGENASE 2; CYTOKINES; DIETARY SUPPLEMENTS; MATRIX METALLOPROTEINASE 3; MICE, INBRED DBA; OLIVE OIL; PROSTAGLANDIN-E SYNTHASES; STAT3 TRANSCRIPTION FACTOR;

EID: 84954350442     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500304     Document Type: Article

References (50)

1. McInnes, I. B., Schett, G., The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011, 365, 2205-2219.
2. Jutley, G., Raza, K., Buckley, C. D., New pathogenic insights into rheumatoid arthritis. Curr. Opin. Rheumatol. 2015, 27, 249-255.
3. Yamanaka, H., TNF as a target of inflammation in rheumatoid arthritis. Endocr. Metab. Immune Disord. Drug Targets 2015, 15, 129-134.
4. Rosillo, M. A., Sanchez-Hidalgo, M., Sanchez-Fidalgo, S., Aparicio-Soto, M. et al., Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis. Eur. J. Nutr. 2015.
5. Li, Y., Wang, S., Wang, Y., Zhou, C. et al., Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway. Transl. Res. 2013, 161, 89-98.
6. Criado, G., Risco, A., Alsina-Beauchamp, D., Perez-Lorenzo, M. J. et al., Alternative p38 MAPKs are essential for collagen-induced arthritis. Arthritis Rheum. 2014, 66, 1208-1217.
7. McCoy, J. M., Wicks, J. R., Audoly, L. P., The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 2002, 110, 651-658.
8. Anderson, A. E., Pratt, A. G., Sedhom, M. A., Doran, J. P. et al., IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis. Ann. Rheum. Dis. 2015.
9. Minamino, T., Christou, H., Hsieh, C. M., Liu, Y. et al., Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. USA 2001, 98, 8798-8803.
10. Rosillo, M. A., Alcaraz, M. J., Sanchez-Hidalgo, M., Fernandez-Bolanos, J. G. et al., Anti-inflammatory and joint protective effects of extra-virgin olive-oil polyphenol extract in experimental arthritis. J. Nutr. Biochem. 2014, 25, 1275-1281.
11. Mateos, R., Trujillo, M., Pereira-Caro, G., Madrona, A., et al., New lipophilic tyrosyl esters. Comparative antioxidant evaluation with hydroxytyrosyl esters. J. Agric. Food Chem. 2008, 56, 10960-10966.
12. Grasso, S., Siracusa, L., Spatafora, C., Renis, M., Tringali, C., Hydroxytyrosol lipophilic analogues: enzymatic synthesis, radical scavenging activity and DNA oxidative damage protection. Bioorg. Chem. 2007, 35, 137-152.
13. Bouallagui, Z., Bouaziz, M., Lassoued, S., Engasser, J. M. et al., Hydroxytyrosol acyl esters: biosynthesis and activities. Appl. Biochem. Biotechnol. 2011, 163, 592-599.
14. Gonzalez-Correa, J. A., Navas, M. D., Lopez-Villodres, J. A., Trujillo, M. et al., Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci. Lett. 2008, 446, 143-146.
15. Correa, J. A., Lopez-Villodres, J. A., Asensi, R., Espartero, J. L. et al., Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Br. J. Nutr. 2009, 101, 1157-1164.
16. Sanchez-Fidalgo, S., Villegas, I., Aparicio-Soto, M., Cardeno, A. et al., Effects of dietary virgin olive oil polyphenols: hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. J. Nutr. Biochem. 2015.
17. Aparicio-Soto, M., Sanchez-Fidalgo, S., Gonzalez-Benjumea, A., Maya, I. et al., Naturally occurring hydroxytyrosol derivatives: hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol modulate inflammatory response in murine peritoneal macrophages. Potential utility as new dietary supplements. J. Agric. Food Chem. 2015, 63, 836-846.
18. Camporeale, A., Poli, V., IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? Front. Biosci. 2012, 17, 2306-2326.
19. Ferrandiz, M. L., Maicas, N., Garcia-Arnandis, I., Terencio, M. C. et al., Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis. Ann. Rheum. Dis. 2008, 67, 1211-1217.
20. Brenes, M., Garcia, A., Garcia, P., Rios, J. J., Garrido, A., Phenolic compounds in Spanish olive oils. J. Agric. Food Chem. 1999, 47, 3535-3540.
21. Mateos, R., Pereira-Caro, G., Saha, S., Cert, R. et al., Acetylation of hydroxytyrosol enhances its transport across differentiated Caco-2 cell monolayers. Food Chem. 2011, 125, 865-872.
22. Rubio, L., Macia, A., Valls, R. M., Pedret, A. et al., A new hydroxytyrosol metabolite identified in human plasma: hydroxytyrosol acetate sulphate. Food Chem. 2012, 134, 1132-1136.
23. Schurgers, E., Billiau, A., Matthys, P., Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma. J. Interferon Cytokine Res. 2011, 31, 917-926.
24. Mullazehi, M., Mathsson, L., Lampa, J., Ronnelid, J., High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset. Ann. Rheum. Dis. 2007, 66, 537-541.
25. Nandakumar, K. S., Andren, M., Martinsson, P., Bajtner, E. et al., Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur. J. Immunol. 2003, 33, 2269-2277.
26. Komatsu, N., Takayanagi, H., Autoimmune arthritis: the interface between the immune system and joints. Adv. Immunol. 2012, 115, 45-71.
27. Noack, M., Miossec, P., Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun. Rev. 2014, 13, 668-677.
28. Azizi, G., Jadidi-Niaragh, F., Mirshafiey, A., Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. Int. J. Rheum. Dis. 2013, 16, 243-253.
29. Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N. et al., Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J. Clin. Invest. 2000, 106, 1229-1237.
30. Nanes, M. S., Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321, 1-15.
31. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G. et al., Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257, 88-91.
32. Jeong, J. G., Kim, J. M., Cho, H., Hahn, W. et al., Effects of IL-1beta on gene expression in human rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 2004, 324, 3-7.
33. Saxne, T., Heinegard, D., Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br. J. Rheumatol. 1992, 31, 583-591.
34. Ally, M. M., Hodkinson, B., Meyer, P. W., Musenge, E. et al., Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013, 2013, 183653.
35. Denarie, D., Constant, E., Thomas, T., Marotte, H., Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients? Mediators Inflamm. 2014, 2014, 537324.
36. Lazarus, M., Kubata, B. K., Eguchi, N., Fujitani, Y. et al., Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch. Biochem. Biophys. 2002, 397, 336-341.
37. Morel, J., Berenbaum, F., Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 2004, 71, 503-510.
38. Feldmann, M., Maini, S. R., Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 2008, 223, 7-19.
39. Makarov, S. S., NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 2001, 3, 200-206.
40. Xie, C., Ma, L., Liu, J., Li, X. et al., SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage. PloS One 2013, 8, e56349.
41. Li, W., Khor, T. O., Xu, C., Shen, G. et al., Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76, 1485-1489.
42. Han, Z., Boyle, D. L., Chang, L., Bennett, B. et al., c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 2001, 108, 73-81.
43. Suzuki, M., Tetsuka, T., Yoshida, S., Watanabe, N. et al., The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett. 2000, 465, 23-27.
44. Matsumoto, M., Sudo, T., Saito, T., Osada, H., Tsujimoto, M., Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 2000, 275, 31155-31161.
45. Aaronson, D. S., Horvath, C. M., A road map for those who don't know JAK-STAT. Science 2002, 296, 1653-1655.
46. de Hooge, A. S., van de Loo, F. A., Koenders, M. I., Bennink, M. B. et al., Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum. 2004, 50, 2014-2023.
47. Bang, S. Y., Kim, J. H., Kim, H. Y., Lee, Y. J. et al., Achyranthes japonica exhibits anti-inflammatory effect via NF-kappaB suppression and HO-1 induction in macrophages. J. Ethnopharmacol. 2012, 144, 109-117.
48. Hayes, J. D., Dinkova-Kostova, A. T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 2014, 39, 199-218.
49. Maicas, N., Ferrandiz, M. L., Brines, R., Ibanez, L. et al., Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease. Antioxid. Redox Signal. 2011, 15, 889-901.
50. Karatas, A., Koca, S. S., Ozgen, M., Dagli, A. F. et al., Pemetrexed ameliorates experimental arthritis in rats. Inflammation 2015, 38, 9-15.